These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 24141015)

  • 1. Dual roles for splice variants of the glucuronidation pathway as regulators of cellular metabolism.
    Rouleau M; Roberge J; Bellemare J; Guillemette C
    Mol Pharmacol; 2014 Jan; 85(1):29-36. PubMed ID: 24141015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-Talk between Alternatively Spliced UGT1A Isoforms and Colon Cancer Cell Metabolism.
    Audet-Delage Y; Rouleau M; Rouleau M; Roberge J; Miard S; Picard F; Têtu B; Guillemette C
    Mol Pharmacol; 2017 Mar; 91(3):167-177. PubMed ID: 28049773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alternatively spliced products of the UGT1A gene interact with the enzymatically active proteins to inhibit glucuronosyltransferase activity in vitro.
    Bellemare J; Rouleau M; Girard H; Harvey M; Guillemette C
    Drug Metab Dispos; 2010 Oct; 38(10):1785-9. PubMed ID: 20610558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical expression of conjugating UGT1A-derived isoforms in normal and tumoral drug-metabolizing tissues in humans.
    Bellemare J; Rouleau M; Harvey M; Popa I; Pelletier G; Têtu B; Guillemette C
    J Pathol; 2011 Feb; 223(3):425-35. PubMed ID: 21171088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relative protein abundance of UGT1A alternative splice variants as a key determinant of glucuronidation activity in vitro.
    Rouleau M; Roberge J; Falardeau SA; Villeneuve L; Guillemette C
    Drug Metab Dispos; 2013 Apr; 41(4):694-7. PubMed ID: 23360619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alternative-splicing forms of the major phase II conjugating UGT1A gene negatively regulate glucuronidation in human carcinoma cell lines.
    Bellemare J; Rouleau M; Harvey M; Têtu B; Guillemette C
    Pharmacogenomics J; 2010 Oct; 10(5):431-41. PubMed ID: 19997083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantification of Hepatic UDP glucuronosyltransferase 1A splice variant expression and correlation of UDP glucuronosyltransferase 1A1 variant expression with glucuronidation activity.
    Jones NR; Sun D; Freeman WM; Lazarus P
    J Pharmacol Exp Ther; 2012 Sep; 342(3):720-9. PubMed ID: 22661630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of Cryptic Donor Splice Sites within the UDP-Glucuronosyltransferase (UGT)1A First-Exon Region Generates Variant Transcripts That Encode UGT1A Proteins with Truncated Aglycone-Binding Domains.
    Hu DG; Marri S; Hulin JA; Ansaar R; Mackenzie PI; McKinnon RA; Meech R
    Drug Metab Dispos; 2024 May; 52(6):526-538. PubMed ID: 38565302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of the UGT2B7 enzyme activity by C-terminally truncated proteins derived from alternative splicing.
    Ménard V; Collin P; Margaillan G; Guillemette C
    Drug Metab Dispos; 2013 Dec; 41(12):2197-205. PubMed ID: 24088326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of the human glucuronosyltransferase UGT1A pathway by splice isoform polypeptides is mediated through protein-protein interactions.
    Bellemare J; Rouleau M; Harvey M; Guillemette C
    J Biol Chem; 2010 Feb; 285(6):3600-3607. PubMed ID: 19996319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of the UGT1A1 bilirubin-conjugating pathway: role of a new splicing event at the UGT1A locus.
    Lévesque E; Girard H; Journault K; Lépine J; Guillemette C
    Hepatology; 2007 Jan; 45(1):128-38. PubMed ID: 17187418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Divergent Expression and Metabolic Functions of Human Glucuronosyltransferases through Alternative Splicing.
    Rouleau M; Tourancheau A; Girard-Bock C; Villeneuve L; Vaucher J; Duperré AM; Audet-Delage Y; Gilbert I; Popa I; Droit A; Guillemette C
    Cell Rep; 2016 Sep; 17(1):114-124. PubMed ID: 27681425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional diversity at the UGT2B7 locus is dictated by extensive pre-mRNA splicing mechanisms that give rise to multiple mRNA splice variants.
    Ménard V; Eap O; Roberge J; Harvey M; Lévesque E; Guillemette C
    Pharmacogenet Genomics; 2011 Oct; 21(10):631-41. PubMed ID: 21881541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic diversity at the UGT1 locus is amplified by a novel 3' alternative splicing mechanism leading to nine additional UGT1A proteins that act as regulators of glucuronidation activity.
    Girard H; Lévesque E; Bellemare J; Journault K; Caillier B; Guillemette C
    Pharmacogenet Genomics; 2007 Dec; 17(12):1077-89. PubMed ID: 18004212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution of uridine diphosphate-glucuronosyltransferase (UGT) expression and activity in cynomolgus monkey tissues: evidence for differential expression of steroid-conjugating UGT enzymes in steroid target tissues.
    Albert C; Barbier O; Vallée M; Beaudry G; Bélanger A; Hum DW
    Endocrinology; 2000 Jul; 141(7):2472-80. PubMed ID: 10875248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation and function of family 1 and family 2 UDP-glucuronosyltransferase genes (UGT1A, UGT2B) in human oesophagus.
    Strassburg CP; Strassburg A; Nguyen N; Li Q; Manns MP; Tukey RH
    Biochem J; 1999 Mar; 338 ( Pt 2)(Pt 2):489-98. PubMed ID: 10024527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of UGT1A and UGT2B mRNA in human normal tissues and various cell lines.
    Nakamura A; Nakajima M; Yamanaka H; Fujiwara R; Yokoi T
    Drug Metab Dispos; 2008 Aug; 36(8):1461-4. PubMed ID: 18480185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extensive splicing of transcripts encoding the bile acid-conjugating enzyme UGT2B4 modulates glucuronidation.
    Lévesque E; Ménard V; Laverdière I; Bellemare J; Barbier O; Girard H; Guillemette C
    Pharmacogenet Genomics; 2010 Mar; 20(3):195-210. PubMed ID: 20139797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Warfarin is an effective modifier of multiple UDP-glucuronosyltransferase enzymes: evaluation of its potential to alter the pharmacokinetics of zidovudine.
    Sun H; Zhang T; Wu Z; Wu B
    J Pharm Sci; 2015 Jan; 104(1):244-56. PubMed ID: 25393417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional characterization of human UDP-glucuronosyltransferase 1A9 variant, D256N, found in Japanese cancer patients.
    Jinno H; Saeki M; Saito Y; Tanaka-Kagawa T; Hanioka N; Sai K; Kaniwa N; Ando M; Shirao K; Minami H; Ohtsu A; Yoshida T; Saijo N; Ozawa S; Sawada J
    J Pharmacol Exp Ther; 2003 Aug; 306(2):688-93. PubMed ID: 12730278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.